Related Experiment Video
Updated: Feb 2, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
Regulation of immune responses by E3 ubiquitin ligase Cbl-b
Rong Tang1, Wallace Y Langdon2, Jian Zhang3
1Department of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, PR China.
Insights
Casitas B lymphoma-b (Cbl-b) regulates both adaptive and innate immunity, impacting T cell activation and host defense. Targeting Cbl-b offers potential therapeutic strategies for immune-related disorders.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Casitas B lymphoma-b (Cbl-b) is a RING finger E3 ubiquitin ligase.
- Cbl-b is a key regulator of adaptive immune responses, influencing T cell activation and tolerance.
- Emerging evidence highlights Cbl-b's role in innate immunity and host defense.
Purpose of the Study:
- To review the multifaceted roles of Cbl-b in both innate and adaptive immunity.
- To summarize recent advancements in understanding Cbl-b's function in immune-mediated diseases.
- To explore the therapeutic potential of targeting Cbl-b for various immune disorders.
Main Methods:
- Literature review of recent studies on Cbl-b.
- Analysis of Cbl-b's molecular mechanisms in immune cell regulation.
- Synthesis of findings related to Cbl-b in host defense and disease pathology.
Main Results:
- Cbl-b is crucial for setting the threshold of T cell activation.
- Cbl-b modulates peripheral T cell tolerance through diverse pathways.
- Cbl-b significantly impacts host defense against pathogens and anti-tumor immunity.
Conclusions:
- Cbl-b is a critical nexus for both innate and adaptive immunity.
- Dysregulation of Cbl-b is implicated in various immune-mediated diseases.
- Targeting Cbl-b presents a promising therapeutic avenue for autoimmune diseases, infections, tumors, and allergic inflammation.
Abstract:
Casitas B lymphoma-b (Cbl-b), a RING finger E3 ubiquitin ligase, has been identified as a critical regulator of adaptive immune responses. Cbl-b is essential for establishing the threshold for T cell activation and regulating peripheral T cell tolerance through various mechanisms. Intriguingly, recent studies indicate that Cbl-b also modulates innate immune responses, and plays a key role in host defense to pathogens and anti-tumor immunity. These studies suggest that targeting Cbl-b may represent a potential therapeutic strategy for the management of human immune-related disorders such as autoimmune diseases, infections, tumors, and allergic airway inflammation. In this review, we summarize the latest developments regarding the roles of Cbl-b in innate and adaptive immunity, and immune-mediated diseases.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Humoral Immune Responses
Cell-mediated Immune Responses
Cells of the Adaptive Immune Response
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

